Article Per Year (5 Year)
p-Index From 2020 - 2025
0
P-Index
This Author published in this journals
All Journal Jurnal Respirasi (JR)
Risnawati Risnawati
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Hospital, Surabaya, Indonesia.
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Tumor Mediastinum Anterior (Yolk Sac Tumor) pada Seorang Laki-Laki Dewasa Muda: Sebuah Kasus yang Jarang: [Yolk Sac Tumor in a Young Man: A Rare Case] Risnawati Risnawati; Laksmi Wulandari
Jurnal Respirasi Vol. 2 No. 2 (2016): Mei 2016
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (944.996 KB) | DOI: 10.20473/jr.v2-I.2.2016.45-51

Abstract

Background: Primary mediastinal yolk sac tumor is an extremely rare and highly malignant tumors occuring in children and young adult. They are more common in men. The most common symptoms on ptesentation were dyspnea, chest pain, cought, fever, night sweat, or weight loss. Primary mediastinal tumor are considered to have poor prognosis. Case: A 18- year-old man who presented with shorthness of breath, chest pain, fever, night sweat, and generalized weakness. He had no significant surgical, familiy or social history. The chest X-Ray and computed tomographic scan of the chest showed a large anterior mediasti nal mass. The serum level of alpha- fetoprotein and β-HCG was elevated. The histological examination revealed the finding of yolk sac tumor. This supported the diagnosis of yolk sac tumor. The patient received a combination chemotherapy consisting of cisplatin, etoposide and bleomycin every 3 weeks for total of 4 cycles. Conclusions: Primary mediastinal yolk sac tumor is a rare tumor. The diagnosis should be made not only by morphological studies but the also the patients age and the elevation of serum alpha-fetoprotein. In spite of modern chemotherapy, the prognosis of mediastinal yolk sac tumor remains poor.
Nutrisi pada Penderita Kanker Paru : [Nutrition Management in Lung Cancer Patients] Risnawati Risnawati; Isnu Pradjoko; Farah Fatma Wati
Jurnal Respirasi Vol. 5 No. 3 (2019): September 2019
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (638.32 KB) | DOI: 10.20473/jr.v5-I.3.2019.91-100

Abstract

World Health Organization data shows that lung cancer is the leading cause of death in the group of deaths due to malignancy. Weight loss is common in lung cancer. Known side effects of chemotherapy and those that affect nutritional status include anorexia, nausea, vomiting, satiety and mucositis. In total 40-60% of lung cancer patients experience unintentional weight loss. Weight loss and reduced nutritional status have been identified as negative prognostic variables for patients. Nutritional disorders during chemotherapy if left untreated can cause interference and delay treatment. Therefore there is a need for nutritional management in patients with lung cancer so that treatment runs smoothly and supports patient health.
Co-Authors Farah Fatma Wati Isnu Pradjoko Laksmi Wulandari